Groupe Hospitalier Pellegrin - Hôpital Pellegrin

Bordeaux 33076

0 studies enrolling now · 3 studies all time

What they study most

Glomerulonephritis, Membranous, Multiple Sclerosis, Relapsing-Remitting, Von Willebrand Disease, antiPLA2R Positive

Studies at this site

• A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) — Completed
• Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed